Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
mitomycin c/rak
Veza se sprema u međuspremnik
15 rezultatima
Inhibitors of endo-exonuclease activity for treating cancer
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to chemotherapeutic agents for treating cancer.
BACKGROUND
Cancer cells proliferate more rapidly than normal cells. The rate of mitosis and DNA replication is therefore significantly greater in cancer cells. Agents that inhibit DNA replication and
Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The present invention is related to the field of molecular and experimental oncology, in particular to the description of a pharmaceutical combination directed to the treatment and/or chemosensibilization of refractory tumors to convencional cytostatics.
PRIOR ART
In the last three
Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The present invention is related to the field of molecular and experimental oncology, in particular to the description of a pharmaceutical combination directed to the treatment and/or chemosensibilization of refractory tumors to convencional cytostatics.
PRIOR ART
In the last three
Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
1. FIELD OF THE INVENTION
The present invention is directed to administration of an nitric oxide (NO) scavenger or an NO synthase inhibitor to enhance the effectiveness of tumor therapy with hypoxic or acidic chemotherapeutic agents or hyperthermia.
2. BACKGROUND OF THE INVENTION
2.1 Hypoxic and
Derivatives of mitomycin C
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
This invention relates to new derivatives of mitomycin C.
The new derivatives of mitomycin C contemplated by the present invention are la-higher aliphatic acyl derivatives of mitomycin C having the general formula: ##STR2## wherein R is an aliphatic saturated or
Combination chemotherapy comprising a liposomal prodrug of mitomycin C
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The subject matter described herein relates to methods for treating patients in need of treatment for a neoplastic condition by a combination of a liposomal prodrug of mitomycin C and a chemotherapeutic agent.
BACKGROUND
Cancer is a leading cause of death in the United States and
Combination therapy comprising a liposomal prodrug of mitomycin C and radiotherapy
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The subject matter described herein relates to methods for treating patients in need of treatment for a neoplastic condition by a combination of a liposomal prodrug of mitomycin C and radiotherapy.
BACKGROUND
Cancer is a leading cause of death in the United States and affects people
Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
1. FIELD OF THE INVENTION
The present invention is directed to administration of a nitric oxide (NO) scavenger or an NO synthesis inhibitor as an antitumor therapy to reduce tumor blood flow and oxygenation or as an adjunct therapy to enhance the effectiveness of tumor therapy with hypoxic or acidic
Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention is directed to administration of a nitric oxide (NO) scavenger or an NO synthesis inhibitor as an antitumor therapy to reduce tumor blood flow and oxygenation or as an adjunct therapy to enhance the effectiveness of tumor therapy with hypoxic or acidic
Method for treating multi-drug resistant tumors
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention relates to a method for reducing the cytotoxicity of mitomycin C, and to a method of administering mitomycin C to a multi-drug resistant cell. Mitomycin C is provided in the form of a prodrug conjugate comprised of a hydrophobic moiety linked to the drug
Amino disulfide thiol exchange products
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present compounds are mitomycin C analogs (Class 548, Subclass 422) in which the 7-amino group is substituted by a disulfide containing organic group. These compounds are inhibitors of experimental animal tumors.
BACKGROUND OF THE INVENTION
Nomenclature--The systematic
Adminiculum for antitumor agents
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
This invention relates to an adminiculum for use in administering mitomycin C and doxorubicin.
Mitomycin C, blue-violet crystals or crystalline powder of molecular formula C.sub.15 H.sub.18 N.sub.4 O.sub.5, combines with tumor cell DNA and degrades it. It also inhibits
Bis-amidines
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION
The present invention refers to mitomycin analogs containing two different amidino groups (Class 260 Subclass 326.24). These compounds are mitomycin C derivatives in which both the quinone amino group and the carbamido nitrogen atom are incorporated within an amidino
Antitumor antibacterial agents
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION
This invention is concerned with a new antitumor antibiotic complex and processes for production, recovery and separation into bioactive components.
Based on present spectral data and available physico-chemical properties, the antitumor antibiotic complex of the present
Mitomycin derivatives
Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
TECHNICAL FIELD
The present invention relates to mitomycin derivatives having anti-tumour activity and pharmaceutical compositions containing the same.
BACKGROUND ART
Mitomycins have excellent anti-tumour activity, whilst they are liable to exhibit certain undesired side effects such as the decrease
Najkompletnija baza ljekovitog bilja potpomognuta znanošću
- Radi na 55 jezika
- Biljni lijekovi potpomognuti znanošću
- Prepoznavanje bilja slikom
- Interaktivna GPS karta - označite bilje na mjestu (uskoro)
- Pročitajte znanstvene publikacije povezane s vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima
